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Abstract Hydrogen peroxide (H2O2) is widely regarded as a
cytotoxic agent whose levels must be minimized by the action of
antioxidant defence enzymes. In fact, H2O2 is poorly reactive in
the absence of transition metal ions. Exposure of certain human
tissues to H2O2 may be greater than is commonly supposed:
substantial amounts of H2O2 can be present in beverages
commonly drunk (especially instant coffee), in freshly voided
human urine, and in exhaled air. Levels of H2O2 in the human
body may be controlled not only by catabolism but also by
excretion, and H2O2 could play a role in the regulation of renal
function and as an antibacterial agent in the urine. Urinary
H2O2 levels are influenced by diet, but under certain conditions
might be a valuable biomarker of ‘oxidative stress’. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Hydrogen peroxide (H2O2) is a pale-blue covalent liquid,
freely miscible with water and apparently able to cross cell
membranes readily, although the pathways it uses to traverse
have not been elucidated [1]. Multiple papers have described
high (usually v50 WM) levels of H2O2 as being cytotoxic to a
wide range of animal, plant and bacterial cells in culture,
although LD50 values and the mode of cell death induced
(apoptosis or necrosis) depend on the cell type used, its phys-
iological state, length of exposure to H2O2, the H2O2 concen-
tration used, and the cell culture media employed [1^5]. It is
therefore widely thought that H2O2 is very toxic in vivo and
must be rapidly eliminated, employing enzymes such as cata-
lases, peroxidases (especially glutathione peroxidases) and
thioredoxin-linked systems [1,6^9]. Paradoxically, however,
acatalasemia in humans [1] appears to produce no signi¢cant
phenotype, nor does ‘knockout’ of glutathione peroxidase in
mice except under certain conditions of abnormally high oxi-
dative stress [10^13].
In chemical terms, H2O2 is poorly reactive: it can act as a
mild oxidizing or as a mild reducing agent, but it does not
oxidize most biological molecules readily, including lipids,
DNA and proteins (unless the latter have hyper-reactive thiol
groups or methionine residues [1,3,14]). The danger of H2O2
largely comes from its ready conversion to the indiscrimin-
ately reactive hydroxyl radical (OH), either by exposure to
ultraviolet light [15]
H2O2ÿ!uv 2OH
or by interaction with a range of transition metal ions, of
which the most important in vivo is probably iron [1,16]
Fe2 H2O2 ! intermediate complexes ferryl?? !
Fe3 OH OH3
Living organisms have evolved mechanisms to sequester tran-
sition metal ions into protein-bound forms that cannot cata-
lyze OH formation and other free radical reactions in vivo.
These mechanisms are especially important in such extracel-
lular £uids as the blood plasma [1,16,17]. Nevertheless, H2O2
can contribute to Fenton chemistry not only by being one of
the substrates but also by providing the other, e.g. by liberat-
ing iron from heme proteins [1,16^19]. Addition of H2O2 to
cells in culture can lead to transition metal ion-dependent
OH-mediated oxidative DNA damage, although this damage
appears to be rapidly repaired provided that the cells are not
rendered non-viable by an excess of H2O2 [20].
However, levels of H2O2 at or below about 20^50 WM seem
to have limited cytotoxicity to many cell types. Indeed, there
is a growing literature showing that H2O2 can be used as an
inter- and intra-cellular signalling molecule [21^26]. The ¢rst
example to be elucidated was the role of H2O2 as a second
messenger in the activation of NFUB in some [23], but not all
[27], cell types. Other examples of signalling roles for H2O2
have accumulated fast [21^26]. Hence these may be a good
reason not to eliminate all the H2O2 generated in vivo; its use
in physiological signalling mechanisms. At sites of in£amma-
tion, H2O2 generated by activated phagocytes appears to
modulate the in£ammatory process, e.g. by up-regulating ex-
pression of adhesion molecules, controlling cell proliferation
or apoptosis and modulating platelet aggregation [3,4,28^33].
2. Exposure of human tissues to H2O2
Hydrogen peroxide is generated in vivo by the dismutation
of superoxide radical (O32 ), both non-enzymatically and cat-
alyzed by superoxide dismutase enzymes. Hydrogen peroxide
is also directly produced by a range of oxidase enzymes in-
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cluding glycollate and monoamine oxidases as well as by the
peroxisomal pathway for L-oxidation of fatty acids [1,6,34,35].
Transgenic mice lacking mitochondrial superoxide dismutase
su¡er severe pulmonary and neurological damage, indicating
the essentiality of removing intra-mitochondrial O32 in vivo
[36^38]. However, with the apparent exception of cardiac
muscle, mitochondria in most tissues appear to have limited
capacity to remove H2O2, in that they readily generate sub-
stantial amounts of H2O2 in vitro and probably in vivo
[1,6,35,39^41]. Although mitochondria contain glutathione
peroxidase and thioredoxin-linked peroxidase activities [42^
44], the e⁄ciency of these enzymes in removing H2O2 is un-
certain given the ease with which mitochondria release H2O2
[1,6,39^41].
It thus seems likely that most or all human cells are exposed
to some level of H2O2, with the mitochondria being an im-
portant source. However, certain tissues may be exposed to
higher H2O2 concentrations.
2.1. The oral cavity, oesophagus and stomach
Several beverages commonly drunk by humans can contain
H2O2 at concentrations above 100 WM, including green and
black tea and especially instant co¡ee [45^47]. When such
beverages are ingested, the H2O2 they contain presumably
rapidly di¡uses into the cells of the oral cavity and upper
part of the gastrointestinal tract [48]. Oral bacteria also pro-
duce H2O2 [49,50], although the resulting levels of exposure of
the oral tissues are uncertain. It is often suggested that H2O2
released into saliva is used by salivary peroxidase to oxidize
thiocyanate (CNS3) into products toxic to certain bacterial
strains [50].
2.2. The respiratory system
The cells lining the respiratory system, in common with the
oral and oesophageal epithelium, are exposed to high O2 con-
centrations (21%) as compared with most other body tissues
[1]. Hydrogen peroxide is present in exhaled air of humans
[51^59] and of rats [60], although it is uncertain whether this
H2O2 originates from oral bacteria [49,50], phagocytes (e.g.
alveolar macrophages, neutrophils in the oral cavity, or neu-
trophils recruited to the lungs in in£ammatory lung diseases)
or other lung cells. Amounts of exhaled H2O2 appear greater
in subjects with in£ammatory lung diseases [52^58] and in
cigarette smokers [59]. Nevertheless, H2O2 is present in the
air exhaled by healthy human subjects [51^59].
2.3. The kidney, urinary tract and bladder
Substantial quantities of H2O2, at concentrations some-
times exceeding 100 WM, can be detected in freshly voided
human urine (Table 1) [61^63], even in babies [64]. The sim-
plest way of demonstrating its presence is to place urine into
an oxygen electrode, and inject catalase through the cap. A
‘spike’ of O2 release results as the H2O2 present is decom-
posed by catalase [63].
The H2O2 detected in human urine appears to arise, at least
in part, by O32 -dependent autoxidation of urinary molecules,
some of which originate from diet [47,63,65]. Traces of super-
oxide dismutase are present in urine [66] : this enzyme, as well
as the acidic pH of urine, should facilitate both enzymic and
non-enzymic dismutation of O32 to H2O2 [1]. The pO2 of
urine within the bladder is below that of ambient air [67,68]
and so the rate of H2O2 generation in urine may well increase
upon voiding. Nevertheless, the high levels of H2O2 that can
be detected in some urine samples (Table 1) strongly suggest
that at least some H2O2 generation occurs within the bladder.
Indeed, H2O2 has been detected in urine sampled by catheter-
ization [69]. Hydrogen peroxide has an antibacterial e¡ect
[1,2,70] and it may be that its presence at high levels in urine
could be advantageous in diminishing infections of the blad-
der and urinary tract. On the other hand, the impact of H2O2
generation in vivo upon the cells lining the kidney tubules,
ureters, bladder and urinary tract must be considered. Indeed,
there are suggestions that H2O2 is involved in modulation of
renal function [71^73]. Another possibility is that excretion of
H2O2 represents a metabolic mechanism for controlling its
levels in the human body. If so, measurement of urinary
H2O2 levels may represent a valuable tool for assessment of
‘oxidative stress’, since H2O2 can be measured rapidly and
simply [63,65]. This suggested route of H2O2 elimination by
excretion is perhaps analogous to certain ¢sh, which appear to
dispose of H2O2 by excreting it through their gills [74].
2.4. Vascular endothelial and circulating blood cells
Some studies have claimed substantial levels of H2O2 (up to
V35 WM) in human blood plasma [75^77], but others have
claimed levels to be very low, at or close to zero [78]. The
latter data seem more credible, since H2O2 added to human
plasma disappears rapidly. In part, it is degraded by the traces
of catalase present, but H2O2 can also react with heme pro-
teins, ascorbate, and protein-SH groups [1,79]. In vivo, H2O2
generated in plasma could also di¡use into erythrocytes, white
cells, endothelial cells and platelets for metabolism. However,
the studies in [75^77] could be interpreted to suggest that
H2O2 can be detected at high levels in plasma under assay
conditions in which its removal is prevented. This implies that
human plasma may be continuously generating H2O2. One
enzyme involved in this process, at least under pathological
conditions, appears to be xanthine oxidase [80]. Levels of
Table 1
Levels of hydrogen peroxide in freshly voided human urine
Gender of subject Age (years) [H2O2] in urine (WM)
Female 18 5.0
Female 19 8.0
Female 19 0.4
Female 21 6.2
Female 22 7.7
Female 25 11.5
Female 27 13.0
Female 35 3.5
Male 20 26.5
Male 21 16.3
Male 23 5.2
Male 26 5.9
Male 28 18.9
Male 30 22.3
Male 34 11.0
Male 49 109.6
Spot urine samples were collected from healthy human volunteers
and assayed immediately. Subjects undertook no special dietary or
other preparation before providing samples. Data are means of rep-
licate determinations on each sample; replicates varied by 6 5%.
H2O2 was analyzed by the ferrous ion oxidation^xylenol orange as-
say. Some data abstracted from [63], the rest provided by Caroline
Manonmani, Mangala Srinivas, Melissa Sim and Yogeshwar Emri-
toll, students enrolled in the Talent Development Programme of the
National University of Singapore.
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circulating and endothelium-bound xanthine oxidase are in-
creased as a result of tissue injury [81,82].
2.5. Ocular tissues
The presence of H2O2, at widely varying levels (in some
cases, 100 WM or more), has been reported in human and
other animal aqueous and vitreous humors [83,84]. The ex-
planation might be essentially the same as that advanced
above to account for the con£icting data reported for blood
plasma, i.e. that ocular £uids constantly generate H2O2, which
is rapidly removed [83]. Any impairment in the capacity of the
lens epithelium, retina or other ocular tissues to dispose of
H2O2 would then result in its accumulation. The origin of
this H2O2 is uncertain, but oxidation of glutathione or ascor-
bate is one possibility [84].
3. Conclusion
Hydrogen peroxide appears to be a ubiquitous molecule.
We exhale it, excrete it and take it in from diet. It can be
detected in drinking water, rain water and sea water [85^89].
These data emphasize the importance of metal ion sequestra-
tion in preventing the toxicity of H2O2 in vivo by decreasing
the occurrence of Fenton chemistry, and help explain why a
failure of such sequestration can produce devastating tissue
damage in almost all organs of the body [1,16].
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